论文部分内容阅读
目的探讨 M 受体阻滞剂治疗Ⅲ型慢性前列腺炎的疗效。方法选取Ⅲ型前列腺炎患者286例,平均年龄31.5岁,平均病程1.8年,分为 M 受体阻滞剂治疗组(舍尼亭)、非甾体消炎镇痛药(消炎痛)治疗组,并随机选用抗生素作为辅助治疗,单纯使用左氧氟沙星治疗组作为对照组,根据治疗前后 NIH-CPSI 评分作为疗效评价指标。结果舍尼亭治疗组有效88例(70.97%),消炎痛治疗组有效32例(41.03%),对照组有效31例(36.9%)。结论 M 受体阻滞剂是治疗Ⅲ型慢性前列腺炎的有效药物之一,其治疗作用可能与参与慢性前列腺炎的免疫调节有关。
Objective To investigate the efficacy of M receptor blocker in the treatment of type Ⅲ chronic prostatitis. Methods A total of 286 patients with type Ⅲ prostatitis were selected. The average age was 31.5 years and the average course of disease was 1.8 years. The patients were divided into two groups: sedation group (shanit), NSAID group (indomethacin group) And randomly selected antibiotics as adjuvant therapy, simple use of levofloxacin treatment group as a control group, according to NIH-CPSI score before and after treatment as indicators of efficacy. Results Seizuretreatment group was effective in 88 cases (70.97%), indomethacin treatment group effective in 32 cases (41.03%), the control group was effective in 31 cases (36.9%). Conclusion M blocker is one of the effective drugs for the treatment of chronic prostatitis type Ⅲ, and its therapeutic effect may be related to the immune regulation involved in chronic prostatitis.